CTB glycoprotein (75 kDa) inhibits IgE releasing, TNF-α and IL-6 expressed by bisphenol A in vivo and in vitro

Food and Chemical Toxicology

Volumn 50, Issue 6, 2012, Pages 2109-2117

  Lee, Jin ^a   Lee, Sei Jung ^b   Lim, Kye Taek ^a  

^a Chonnam National University   (South Korea)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bisphenol A; COX 2; CTB glycoprotein (75 kDa); IgE; IL 6; TNF

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ANTIINFLAMMATORY AGENT; BETA N ACETYLHEXOSAMINIDASE; CUDRANIA TRICUSPIDATA BUREAU GLYCOPROTEIN; CYCLOOXYGENASE 2; GLYCOPROTEIN; HISTAMINE; IMMUNOGLOBULIN E; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PROTEIN C FOS; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; ENDOCRINE DISRUPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHENOL DERIVATIVE;

ALLERGY; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG DOSE COMPARISON; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; FEMALE; HISTAMINE RELEASE; IMMUNOGLOBULIN PRODUCTION; IN VITRO STUDY; IN VIVO STUDY; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL LINE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; HYPERSENSITIVITY; INFLAMMATION; MAST CELL; METABOLISM; MORACEAE; REAL TIME POLYMERASE CHAIN REACTION;

MACLURA TRICUSPIDATA; MUS;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CYCLOOXYGENASE 2; CYTOKINES; ENDOCRINE DISRUPTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HEXOSAMINIDASES; HISTAMINE RELEASE; HYPERSENSITIVITY; IMMUNOGLOBULIN E; INFLAMMATION; INTERLEUKIN-6; MAST CELLS; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASES; MORACEAE; PHENOLS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84860122717     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.03.043     Document Type: Article

References (45)

1. 2+ signals in pancreatic alpha-cells through a nonclassical membrane estrogen receptor within intact islets of Langerhans. Environ. Health Perspect. 2005, 113:969-977.
2. Berin M.C. Mechanisms of allergic sensitization to foods: bypassing immune tolerance pathways. Immunol. Allergy Clin. North Am. 2012, 32:1-10.
3. Bochenek G., Nizankowska E., Gielicz A., Swierczynska M., Szczeklik A. Plasma 9alpha, 11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma. Thorax 2004, 59:459-464.
4. Brown J.M., Nemeth K., Kushnir-Sukhov N.M., Metcalfe D.D., Mezey E. Bone marrow stromal cells inhibit mast cell function via a COX2-dependent mechanism. Clin. Exp. Allergy 2011, 41:526-534.
5. Carter A.B., Monick M.M., Hunninghake G.W. Both Erk and p38 kinases are necessary for cytokine gene transcription. Am. J. Respir. Cell Mol. Biol. 1999, 20:751-758.
6. Cobb M.H., Goldsmith E.J. Dimerization in MAP-kinase signaling. Trends Biochem. Sci. 2000, 25:7-9.
7. Colborn T., vom Saal F.S., Soto A.M. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ. Health Perspect. 1993, 101:378-384.
8. Drazen J.M., Arm J.P., Austen K.F. Sorting out the cytokines of asthma. J. Exp. Med. 1996, 183:1-5.
9. Filardo E.J., Thomas P. GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol. Metab. 2005, 16:362-367.
10. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 1982, 126:131-138.
11. Gilfillan A.M., Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat. Rev. Immunol. 2006, 6:218-230.
12. Hess-Wilson J.K., Boldison J., Weaver K.E., Knudsen K.E. Xenoestrogen action in breast cancer: impact on ER-dependent transcription and mitogenesis. Breast Cancer Res. Treat. 2006, 96:279-292.
13. Hong C.C., Shimomura-Shimizu M., Muroi M., Tanamoto K. Effect of endocrine disrupting chemicals on lipopolysaccharide- induced tumor necrosis factor-alpha and nitric oxide production by mouse macrophages. Biol. Pharm. Bull. 2004, 27:1136-1139.
14. Hsu Y.W., Chi K.H., Huang W.C., Lin W.W. Ceramide inhibits lipopolysaccharide-mediated nitric oxide synthase and cyclooxygenase-2 induction in macrophages: effects on protein kinases and transcription factors. J. Immunol. 2001, 166:5388-5397.
15. Encyclopedia of Chinese Medicinal Substances 1977, vol. 1502. Jiangsu New Medical College, Shanghai Peoples Publisher, Shanghai.
16. Joo H.Y., Lim K.T. Glycoprotein isolated from Cudrania tricuspidata Bureau inhibits iNO and COX-2 expression through modulation of NF-κB in LPS-stimulated RAW264.7 cells. Environ. Toxicol. Pharmacol. 2009, 27:247-252.
17. Kang J.H., Kondo F., Katayama Y. Human exposure to bisphenol A. Toxicology 2006, 226:79-89.
18. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der B.B., Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139:4252-4263.
19. Lee M.H., Chung S.W., Kang B.Y., Park J., Lee C.H., Hwang S.Y., Kim T.S. Enhanced interleukin-4 production in CD4+ T cells and elevated immunoglobulin E levels in antigen-primed mice by bisphenol A and nonylphenol, endocrine disruptors: involvement of nuclear factor-AT and Ca2+. Immunology 2003, 109:76-86.
20. Lee Y.N., Tuckerman J., Nechushtan H., Schutz G., Razin E., Angel P. C-Fos as a regulator of degranulation and cytokine production in FcepsilonRI-activated mast cells. J. Immunol. 2004, 173:2571-2577.
21. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
22. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
23. Matsubara M., Masaki S., Ohmori K., Karasawa A., Hasegawa K. Differential regulation of IL-4 expression and degranulation by anti-allergic olopatadine in rat basophilic leukemia (RBL-2H3) cells. Biochem. Pharmacol. 2004, 67:1315-1326.
24. Moller A., Henz B.M., Grutzkau A., Lippert U., Aragane Y., Schwarz T., Kruger-Krasagakes S. Comparative cytokine gene expression: regulation and release by human mast cells. Immunology 1998, 793:289-295.
25. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
26. Narita S., Goldblum R.M., Watson C.S., Brooks E.G., Estes D.M., Curran E.M., Midoro-Horiuti T. Environmental estrogens induce mast cell degranulation and enhance IgE-mediated release of allergic mediators. Environ. Health Perspect. 2007, 2007(115):48-52.
27. Neville D.M., Glossmann H. Molecular weight determination of membrane protein and glycoprotein subunits by discontinuous gel electrophoresis in dodecyl sulfate. Meth. Enzymol. 1974, 32:92-102.
28. Oh P.S., Lee S.J., Lim K.T. Glycoprotein isolated from Rhus verniciflua Stokes inhibits inflammation-related protein and nitric oxide production in LPS-stimulated RAW 264.7 cells. Biol. Pharm. Bull. 2007, 30:111-116.
29. O'Mahony L., Akdis M., Akdis C.A. Regulation of the immune response and inflammation by histamine and histamine receptors. J. Allergy Clin. Immunol. 2011, 128:1153-1162.
30. Ooi V.E., Liu F. Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr. Med. Chem. 2000, 7:715-729.
31. Palanki M.S. Inhibitors of AP-1 and NF-kappa B mediated transcriptional activation: therapeutic potential in autoimmune diseases and structural diversity. Curr. Med. Chem. 2002, 9:219-227.
32. Parronchi P., De Carli M., Manetti R., Simonelli C., Sampognaro S., Piccinni M.P., Macchia D., Del Prete G., Romagnani S. IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J. Immunol. 1992, 149:2977-2983.
33. Pawankar R. Mast cells in allergic airway disease and chronic rhinosinusitis. Chem. Immunol. Allergy 2005, 87:111-129.
34. Safe S.H., Pallaroni L., Yoon K., Gaido K., Ross S., McDonnell D. Problems for risk assessment of endocrine-active estrogenic compounds. Environ. Health Perspect. 2002, 110:925-929.
35. Scherle P.A., Jones E.A., Favata M.F., Daulerio A.J., Covington M.B., Nurnberg S.A., Magolda R.L., Trzaskos J.M. Inhibition of MAP kinase prevents cytokine and rostaglandin E2 production in lipopolysaccharide-stimulated monocytes. J. Immunol. 1998, 161:5681-5686.
36. Segura J.J., Jimenez-Rubio A., Pulgar R., Olea N., Guerrero J.M., Calvo J.R. In vitro effect of the resin component bisphenol A on substrate adherence capacity of macrophages. J. Endod. 1999, 25:341-344.
37. Shore P.A., Brukhalter A., Cohn V.H. A method for the fluorometric assay of histamine in tissues. J. Pharmacol. Exp. Ther. 1959, 127:182-186.
38. Stoker T.E., Robinette C.L., Britt B.H., Laws S.C., Cooper R.L. Prepubertal exposure to compounds that increase prolactin secretion in the male rat: effect on the adult prostate. Biol. Reprod. 1996, 6:1636-1643.
39. Takao T., Nanamiya W., Nagano I., Asaba K., Kawabata K., Hashimoto K. Exposure with the environmental estrogen bisphenol A disrupts the male reproductive tract in young mice. Life Sci. 1999, 65:2351-2357.
40. Takayanagi, Tokunaga T., Liu X., Okada H., Matsushima A., Shimohigashi Y. Endocrine disruptor bisphenolAstrongly binds tohumanestrogen-related receptor gamma (ERRgamma) with high constitutive activity. Toxicol. Lett. 2006, 167:5-105.
41. Thomas P.S. Tumour necrosis factor-a: the role of this multifunctional cytokine in asthma. Immunol. Cell Biol. 2001, 79:132-140.
42. Watson C.S., Bulayeva N.N., Wozniak A.L., Alyea R.A. Xenoestrogens are potent activators of nongenomic estrogenic responses. Steroids 2007, 72:124-134.
43. Welshons W.V., Nagel S.C., Vom Saal F.S. Large effects from small exposures III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 2006, 147:S56-S69.
44. Yamashita U., Sugiura T., Yoshida Y., Kuroda E. Effect of endocrine disrupters on macrophage function in vitro. J. UOEH 2005, 27:1-10.
45. Yurino H., Ishikawa S., Sato T., Akadegawa K., Ito T., Ueha S., Inadera H., Matsushima K. Endocrine disruptors (environmental estrogens) enhance autoantibody production by B1 cells. Toxicol. Sci. 2004, 81:139-147.